Anti-Bribery Policy

BioStackHQ prohibits bribery, corruption and any form of improper payment or advantage intended to influence business decisions.

This Policy applies to all business activity undertaken for BioStack HQ, including dealings with public officials, customers, suppliers, intermediaries, advisers, charitable organisations and other third parties.

The responsible owner shall maintain proportionate procedures, records and review arrangements to give effect to this provision. Any exception requires appropriate authority, documentation and, where the risk warrants it, consultation with the Office of Legal & Governance or another competent control function.

Gifts, hospitality, donations, sponsorships, facilitation payments, expenses and third-party engagements must be assessed against documented risk and approval requirements. Books and records must accurately reflect transactions; concealed, misleading or off-book arrangements are prohibited.

Partners, suppliers and representatives are expected to maintain standards consistent with this policy.

This Policy applies to all business activity undertaken for BioStack HQ, including dealings with public officials, customers, suppliers, intermediaries, advisers, charitable organisations and other third parties.

Where third parties act for, provide services to or receive protected information from BioStack HQ, the Group may apply proportionate diligence, contractual safeguards, audit rights, approval requirements and remediation measures. Responsibility cannot be avoided by delegating an activity to another person or organisation.

Gifts, hospitality, donations, sponsorships, facilitation payments, expenses and third-party engagements must be assessed against documented risk and approval requirements. Books and records must accurately reflect transactions; concealed, misleading or off-book arrangements are prohibited.

Appropriate controls and reviews may be implemented to support compliance with anti-bribery obligations.

This Policy applies to all business activity undertaken for BioStack HQ, including dealings with public officials, customers, suppliers, intermediaries, advisers, charitable organisations and other third parties.

Implementation is risk-based and may differ according to the sensitivity of the activity, the systems involved, the scale of potential harm and the operational context. Control effectiveness is reviewed periodically and following material change, identified weakness or incident.

Gifts, hospitality, donations, sponsorships, facilitation payments, expenses and third-party engagements must be assessed against documented risk and approval requirements. Books and records must accurately reflect transactions; concealed, misleading or off-book arrangements are prohibited.